[1]
C. Kollmannsberger, D. Soulieres, R. Wong, A. Scalera, R. Gaspo, and G. Bjarnason, “Sunitinib therapy for metastatic renal cell carcinoma: recommendations for management of side effects”, CUAJ, vol. 1, no. 2S, Dec. 2012.